Skip to main content

Functioning Adenomas

  • Chapter
Neuro-Oncology of CNS Tumors

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 249.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Molitch ME. Disorders of prolactin secretion. Endocrinol Metab Clin North Am 2001; 30:585–610.

    Article  PubMed  CAS  Google Scholar 

  2. Barkan AL, Chandler WF. Giant pituitary adenoma with falsely low serum prolactin: the pitfall of the ‘high dose hook effect’. Neurosurgery 1998; 42:913–915.

    PubMed  CAS  Google Scholar 

  3. Hattori N. Macroprolactinemia: a new cause of hyperprolactinemia. J Pharmacol Sci 2003; 92:171–177.

    Article  PubMed  CAS  Google Scholar 

  4. Colao A, Di Sarno A, Cappabianca P, Di Somma C, Pivonello R, Lombardi G. Withdrawal of long-term cabergoline therapy for tumoral and nontumoral hyperprolactinemia. NEJM 2003; 349:2023–2033.

    Article  PubMed  CAS  Google Scholar 

  5. Colao A, Di Sarno A, Landi ML, Scavuzzo F, Cappabianca P, Pivonello R, Volpe R, Di Salle F, Cirillo S, Annunziato L, Lombardi G. Macroprolactinoma shrinkage during cabergoline treatment is greater in naive patients than in patients pretreated with other dopamine agonists: a prospective study in 110 patients. JCEM 2000; 85:2247–2252.

    PubMed  CAS  Google Scholar 

  6. Lüdecke DK, Herrmann H-D, Hörman C, Desaga U, Saeger W. Microsurgery and combination with dopamine agonist treatment of prolactinomas. In: Prolactin and prolactinomas, eds. Tolis G et al., Raven Press, New York, 1983:453–467.

    Google Scholar 

References

  1. Melmed S, Casanueva FF, Cavagnini F, Chanson P, Frohman L, Grossman A, Ho K, Kleinberg D, Lamberts S, Laws E, Lombardi G, Vance ML, von Werder K, Wass J, Giustina A. Guidelines for acromegaly management. J Clin Endocrinol Metab 2002; 87:4054–8.

    Article  PubMed  CAS  Google Scholar 

  2. Giustina A, Barkan A, Casanueva FF, Cavagnini F, Frohman L, Ho K, Veldhuis J, Wass J, von Werder K, Melmed S. Criteria for cure of acromegaly: a consensus statement. J Clin Endocrinol Metab 2000; 85:526–9.

    Article  PubMed  CAS  Google Scholar 

  3. Lüdecke DK. Recent developments in the treatment of acromegaly. Neurosurg Rev 1985; 8: 167–73.

    PubMed  Google Scholar 

  4. Freda PU. Somatostatin analogs in acromegaly. J Clin Endocrinol Metab 2002; 87:3013–18.

    Article  PubMed  CAS  Google Scholar 

  5. Clemmons DR, Chihara K, Freda PU, Ho KKY, Klibanski A, Melmed S, Shalet SM, Strasburger CJ, Trainer PJ, Thorner MO. Optimizing control of acromegaly: integrating a growth hormone receptor antagonist into the treatment algorithm. J Clin Endocrinol Metab 2003; 88:4759–67.

    Article  PubMed  CAS  Google Scholar 

  6. Biermasz NR, van Dulken H, Roelfsema F. Long-term follow-up results of postoperative radiotherapy in 36 patients with acromegaly. J Clin Endocrinol Metab 2000; 85:2476–82.

    PubMed  CAS  Google Scholar 

  7. Attanasio R, Epaminonda P, Motti E, Giugni E, Ventrella L, Cozzi R, Farabola M, Loli P, Beck-Peccoz P, Arosio M. Gamma-knife radiosurgery in acromegaly: a 4-year follow-up study. J Clin Endocrinol Metab 2003; 88:3105–12.

    PubMed  CAS  Google Scholar 

References

  1. Abe T, Lüdecke DK. Effects of preoperative octreotide treatment on different subtypes of 90 growth hormone-secreting pituitary adenomas and outcome in one surgical center. Eur J Endocrinol 2001; 145:137–45

    Article  PubMed  CAS  Google Scholar 

  2. Beck-Peccoz P, Brucker-Davis F, Persani L, Smallridge RC, Weintraub BD. Thyrotropin-secreting pituitary tumors. Endocr Rev 1996; 17:610–38.

    Article  PubMed  CAS  Google Scholar 

  3. Buchfelder M, Fahlbusch R. Thyrotroph adenomas. In: Thapar K, Kovacs K, Scheithauer BW, Lloyd RV, eds. Diagnosis and management of pituitary tumors. Totowa, NJ: Human Press, 2001:333–42.

    Google Scholar 

  4. Chanson P, Weintraub BD, Harris AG. Octreotide therapy for thyroid stimulating-secreting pituitary adenomas. A follow-up of 52 patients. Ann Intern Med 1993; 119:236–40.

    PubMed  CAS  Google Scholar 

  5. Kourides IA, Ridgway EC, Weintraub BD, Bigos ST, Gershengorn MC, Maloof F. Thyrotropin-induced hyperthyroidism: use of α and β subunit levels to identify patients with primary tumors. J Clin Endocrinol Metab 1977; 45:534–43.

    Article  PubMed  CAS  Google Scholar 

  6. Losa M, Giovanelli M, Persani L, Mortini P, Faglia G, Beck-Peccoz P. Criteria of cure and follow-up of central hyperthyroidism due to thyrotropin-secreting pituitary adenomas. J Clin Endocrinol Metab 1996; 81:3084–90.

    Article  PubMed  CAS  Google Scholar 

  7. McCutcheon IE, Weintraub BD, Oldfield EH. Surgical treatment of thyreotroph adenomas. J Neurosurg 1990; 73:674–83.

    PubMed  CAS  Google Scholar 

  8. Saeger W, Lüdecke DK. Pituitary adenomas with hyperfunction of TSH: frequency, histological classification, immunocytochemistry and ultrastructure. Virchows Arch [Pathol Anat] 1982; 394:255–67.

    CAS  Google Scholar 

References

  1. Asa SL, Kovacs K, Tindall GT, Barrow DL, Horvath E, Vecsei P. Cushing’s disease associated with an intrasellar gangliocytoma producing corticotropin-releasing factor. Ann Intern Med 1984; 101:789–793.

    PubMed  CAS  Google Scholar 

  2. Cushing H. The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism). Bull Johns Hopkins Hosp 1932; 50:137–195.

    Google Scholar 

  3. Flitsch J, Spitzner S, Lüdecke DK. Emotional disorders in patients with different types of pituitary adenomas and factors affecting the diagnostic process. Exp Clin Endocrinol Diabetes 2000; 108:480–485.

    Article  PubMed  CAS  Google Scholar 

  4. Lüdecke DK. Intraoperative measurement of adrenocorticotrophic hormone in peripituitary blood in Cushing’s disease. Neurosurg 1989; 24:201–204.

    Google Scholar 

  5. Lüdecke DK, Flitsch J, Knappe UJ, Saeger W. Cushing’s disease: a surgical view. J Neuro-Oncol 2001; 54:151–166.

    Google Scholar 

  6. Mahmoud-Ahmed AS, Suh JH. Radiation therapy for Cushing’s disease: a review. Pituitary 2002; 5:175–180.

    Article  PubMed  CAS  Google Scholar 

  7. Nelson DH, Meakin JF, Dealy JW, Matson DD, Emerson K, Thorn GW. ACTH-producing tumor of the pituitary gland. N Engl J Med 1958; 259:161–164.

    PubMed  CAS  Google Scholar 

  8. Newell-Price J, Trainer P, Besser M, Grossman A. The diagnosis and differential diagnosis of Cushing’s syndrome and pseudo-Cushing’s states. Endocr Rev 1998; 19:647–672.

    Article  PubMed  CAS  Google Scholar 

  9. Nieman LK. Medical therapy of Cushing’s disease. Pituitary 2002; 5:77–82.

    Article  PubMed  CAS  Google Scholar 

  10. Oldfield EH, Chrousos GP, Schulte HM, Schaaf M, Mc Keever PE, Krudy AG, Cutler Jr GB, Loriaux DL, Doppman JL. Preoperative lateralization of ACTH-secreting pituitary microadenomas by bilateral and simultaneous inferior petrosal venous sinus sampling. N Engl J Med 1985; 312:100–103.

    Article  PubMed  CAS  Google Scholar 

  11. Saeger W, Wilczak P, Lüdecke DK, Buchfelder M, Fahlbusch R. Hormone markers in pituitary adenomas: Changes within last decade resulting from improved method. Endocri Pathol 2003; 14:49–54.

    CAS  Google Scholar 

  12. Semple PL, Laws Jr ER. Complications in a contemporary series of patients who underwent transsphenoidal surgery. J Neurosurg 1999; 91:175–179.

    PubMed  CAS  Google Scholar 

  13. Solcia E, Klöppel G, Sobin LH, Capella C, de Lellis RA, Heitz PhU, Horvath E, Kovacs K, Lack EE, Lloyd RJ, Rosai J, Scheithauer BW. Histological typing of endocrine tumors. 2nd edition. Springer, Berlin-Heidelberg-New York-Barcelona-Hong Kong-London-Milan-Paris-Singapore-Tokyo, 2000

    Google Scholar 

  14. Teramoto A, Nemoto S, Takakura K, Sasaki Y, Machida T. Selective venous sampling directly from the cavernous sinus in Cushing’s syndrome. J Clin Endocrinol Metab 1993; 76:637–641.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Lüdecke, D.K., Abe, T., Flitsch, J., Petersen, S., Saeger, W. (2006). Functioning Adenomas. In: Tonn, JC., Grossman, S.A., Rutka, J.T., Westphal, M. (eds) Neuro-Oncology of CNS Tumors. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-31260-9_12

Download citation

  • DOI: https://doi.org/10.1007/3-540-31260-9_12

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-25833-9

  • Online ISBN: 978-3-540-31260-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics